Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037219
Filing Date
2022-11-09
Accepted
2022-11-09 16:39:49
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20220930.htm   iXBRL 10-Q 2561581
2 EX-31.1 rxdx-ex311_7.htm EX-31.1 20880
3 EX-31.2 rxdx-ex312_6.htm EX-31.2 20608
4 EX-32.1 rxdx-ex321_9.htm EX-32.1 10277
5 EX-32.2 rxdx-ex322_8.htm EX-32.2 10057
  Complete submission text file 0001564590-22-037219.txt   9696248

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20220930.xsd EX-101.SCH 68915
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20220930_cal.xml EX-101.CAL 52507
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20220930_def.xml EX-101.DEF 255222
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20220930_lab.xml EX-101.LAB 534905
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20220930_pre.xml EX-101.PRE 436533
70 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20220930_htm.xml XML 1735854
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

EIN.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 221373307
SIC: 2834 Pharmaceutical Preparations